Skip to content

Jehovah’s Witnesses

Select language English

Medicine and Surgery

Clinical strategies for managing hemorrhage and anemia without allogeneic blood transfusion.

Pediatrics

Clinical strategies for managing neonatal and pediatric patients without allogeneic blood transfusion.

Diseases and Conditions

Clinical strategies for managing specific diseases or conditions without allogeneic blood transfusion.

Bioethics and Law

Ethical, legal, and social factors for health-care professionals to consider when treating Jehovah’s Witnesses.


Featured Articles

Eltrombopag added to standard immunosuppression for aplastic anemia.

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

Source‎: N Engl J Med 2017;376(16):1540-50.

Indexed‎: PubMed 28423296

DOI‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Source‎: Lancet 2017;389(10084):2105-16.

Indexed‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509

International consensus statement on the peri-operative management of anaemia and iron deficiency.

Munoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, Liumbruno GM, Lasocki S, Meybohm P, Rao Baikady R, Richards T, Shander A, So-Osman C, Spahn DR, Klein AA.

Source‎: Anaesthesia 2017;72(2):233-47.

Indexed‎: PubMed 27996086

DOI‎: 10.1111/anae.13773

https://www.ncbi.nlm.nih.gov/pubmed/27996086

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies.

Jacobson AE, Shah N, Setty BA

Source‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indexed‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377

Efficacy of intraoperative cell salvage in decreasing perioperative blood transfusion rates in first-time cardiac surgery patients: a retrospective study.

Côté CL, Yip AM, MacLeod JB, O'Reilly B, Murray J, Ouzounian M, Brown CD, Forgie R, Pelletier MP, Hassan A

Source‎: Can J Surg 2016;59(5):330-6.

Indexed‎: PubMed 27668331

DOI‎: 10.1503/cjs.002216

http://www.ncbi.nlm.nih.gov/pubmed/27668331

Tranexamic acid in patients undergoing coronary-artery surgery.

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Source‎: N Engl J Med 2017;376(2):136-48.

Indexed‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Source‎: Transfusion 2017;57(6):1347-58.

Indexed‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313

Perioperative management of a child with hypoplastic left heart syndrome of the Jehovah's Witness faith presenting for hybrid comprehensive stage II procedure.

Karuppiah S, Mckee C, Hodge A, Galantowicz M, Tobias J, Naguib A.

Source‎: J Extra Corpor Technol 2016;48(3):141-7.

Indexed‎: PubMed 27729708

https://www.ncbi.nlm.nih.gov/pubmed/27729708


The medical section of jw.org is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.